Uptake across the blood-brain barrier and tissue distribution of enterostatin after peripheral administration in rats

Physiology and Behavior

Volumn 77, Issue 1, 2002, Pages 5-10

  Koizumi, Miwako ^a   Nakanishi, Yukiko ^a   Sato, Hitoshi ^b   Morinaga, Yasushi ^b   Ido, Tatuo ^c   Kimura, Shuichi ^a  

^a SHOWA WOMEN'S UNIVERSITY   (Japan)

^b AJINOMOTO CO INC   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

3H VPDPR; Body distribution; Brain distribution; Enterostatin; TLC (thin layer chromatography); VPDPR

Indexed keywords

ENTEROSTATIN; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CEREBELLUM; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; DRUG UPTAKE; FRONTAL CORTEX; HIPPOCAMPUS; ISOTOPE LABELING; MALE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; RADIOACTIVITY; RAT; TISSUE DISTRIBUTION;

EID: 0036710601     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(02)00805-3     Document Type: Article

References (15)

1. Banks W.A., Kastin A.J., Huang W., Jaspan J.B., Maness L.M. Leptin enters the brain by a saturable system independent of insulin. Peptides. 17:1996;305-311.
2. Bouras M., Huneau J.F., Luengo C., Erlanson-Albertsson C., Tome D. Metabolism of enterostatin in rat intestine, brain membranes, and serum: differential involvement of proline-specific peptidases. Peptides. 16:1995;399-405.
3. Duffy K.R., Pardridge W.M. Blood-brain barrier trancytosis of insulin in developing rabbits. Brain Res. 420:1987;32-38.
4. Egashira T., Takayama F., Yamanaka Y., Takada K., Takeda H., Matsumiya T. Day/night variation of 5-hydroxyindole acetic acid concentration in rat cerebrospinal fluid after acute and long-term administration of a selective serotonin reuptake inhibitor, fluvoxamine. Jpn J Pharmacol. 83:2000;344-347.
5. Erlanson-Albertsson C., Larsson A. A possible function of pancreatic procolipase activation peptide in appetite regulation. Biochimie. 70:1988;1245-1250.
6. Erlanson-Albertsson C., Mei J., Okada S., York D., Bray G.A. Pancreatic procolipase propeptide, enterostatin, specifically inhibits fat intake. Physiol Behav. 49:1991;1191-1194.
7. Erlanson-Albertsson C., Larsson A. The activation peptide of pancreatic procolipase decreases food intake in rats. Regul Pept. 22:1988;325-331.
8. Koizumi M., Sato H., Seguro K., Ide H., Morinaga Y., Kimura S. Effects of enterostatin (Val-Pro-Asp-Pro-Arg) on fat intake and blood levels of glucose and insulin in rats. Methods Find Exp Clin Pharmacol. 23:2001;235-239.
9. Ling L., York D.A. Changes in the microstructure of feeding after administration of enterostatin into the paraventricular nucleus and the amygdala. Peptides. 19:1998;557-562.
10. Ookuma M., York D.A. Inhibition of insulin release by enterostatin. Int J Obese Relat Metab Disord. 22:1998;800-805.
11. Mei J., Erlanson-Albertsson C. Effect of enterostatin given intravenously and intracerebroventricularly on high-fat feeding in rats. Regul Pept. 41:1992;209-218.
12. Mei J., Erlanson-Albertsson C. Plasma insulin in response to enterostatin and effect of adrenalectomy in rat. Obese Res. 4:1996;513-520.
13. Okada S., York D.A., Bray G.A., Erlanson-Albertsson C. Enterostatin (Val-Pro-Asp-Pro-Arg), the activation peptide of procolipase, selectively reduced fat intake. Physiol Behav. 49:1991;1185-1189.
14. Rippe C., Rippe B., Erlanson-Albertsson C. Capillary diffusion capacity and tissue distribution of pancreatic procolipase in rat. Am J Physiol. 275:1998;G1179-G1184.
15. Wada Y., Egashira T., Takayama F., Yamanaka Y., Takada K., Takeda H., Matsumiya T. Variation of monoamines and their metabolite contents in the cerebrospinal fluid of conscious rats. Jpn J Pharmacol. 78:1998;237-240.